Ask AI
Treating ET and PV

CME

Global Experts Discuss Current and Emerging Treatments for ET and PV

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: May 05, 2026

Expiration: November 04, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following is an LSD1 inhibitor that has shown activity in previously treated ET and is currently in phase III assessment?